Xolair
Payments companies reported to CMS as associated with Xolair. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Xolair, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Xolair
These are the largest totals companies reported as associated with Xolair. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Scott Commins | Chapel Hill, NC | Allergy & Immunology | $132,277.26 |
| Joseph Habboushe | New York, NY | Emergency Medicine | $116,250.00 |
| Graham Walker | Stanford, CA | Emergency Medicine | $116,250.00 |
| Mark Scarupa | Wheaton, MD | Allergy & Immunology | $99,789.80 |
| Travis Miller | Roseville, CA | Allergy | $69,071.62 |
| Joseph Diaz | San Antonio, TX | Allergy & Immunology | $67,119.18 |
| Weily Soong | Birmingham, AL | $65,177.70 | |
| Matthew Greenhawt | Aurora, CO | Pediatric Allergy/Immunology | $64,654.25 |
| Syed Mustafa | Rochester, NY | Allergy & Immunology | $64,537.86 |
| Theodore Kelbel | Grand Rapids, MI | Allergy & Immunology | $63,746.76 |
Prescribed Xolair?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.